img

Global Fatty Liver Treatment Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Fatty Liver Treatment Market Research Report 2024

Fatty liver disease is one of the most common liver dysfunction where the triglyceride fat accumulates in liver cells.
According to MRAResearch’s new survey, global Fatty Liver Treatment market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Fatty Liver Treatment market research.
The major risks associated with fatty liver disease are alcoholic cirrhosis, cardiovascular disorder, metabolic syndrome and biliary cirrhosis among others.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Fatty Liver Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Cardax
Daewoong
Roche
Glenmark
GW
Limerick BioPharma
Merck
Novartis
Orchid
AstraZeneca
Segment by Type
Thiazolidinedione
Vitamin E
Metformin Statins
Polyunsaturated Fatty Acids
Angiotensin Receptor Blockers
Pentoxifylline

Segment by Application


Hospitals and Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Fatty Liver Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fatty Liver Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Thiazolidinedione
1.2.3 Vitamin E
1.2.4 Metformin Statins
1.2.5 Polyunsaturated Fatty Acids
1.2.6 Angiotensin Receptor Blockers
1.2.7 Pentoxifylline
1.3 Market by Application
1.3.1 Global Fatty Liver Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals and Clinics
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Fatty Liver Treatment Market Perspective (2018-2033)
2.2 Fatty Liver Treatment Growth Trends by Region
2.2.1 Global Fatty Liver Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Fatty Liver Treatment Historic Market Size by Region (2018-2023)
2.2.3 Fatty Liver Treatment Forecasted Market Size by Region (2024-2033)
2.3 Fatty Liver Treatment Market Dynamics
2.3.1 Fatty Liver Treatment Industry Trends
2.3.2 Fatty Liver Treatment Market Drivers
2.3.3 Fatty Liver Treatment Market Challenges
2.3.4 Fatty Liver Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fatty Liver Treatment Players by Revenue
3.1.1 Global Top Fatty Liver Treatment Players by Revenue (2018-2023)
3.1.2 Global Fatty Liver Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Fatty Liver Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Fatty Liver Treatment Revenue
3.4 Global Fatty Liver Treatment Market Concentration Ratio
3.4.1 Global Fatty Liver Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fatty Liver Treatment Revenue in 2022
3.5 Fatty Liver Treatment Key Players Head office and Area Served
3.6 Key Players Fatty Liver Treatment Product Solution and Service
3.7 Date of Enter into Fatty Liver Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Fatty Liver Treatment Breakdown Data by Type
4.1 Global Fatty Liver Treatment Historic Market Size by Type (2018-2023)
4.2 Global Fatty Liver Treatment Forecasted Market Size by Type (2024-2033)
5 Fatty Liver Treatment Breakdown Data by Application
5.1 Global Fatty Liver Treatment Historic Market Size by Application (2018-2023)
5.2 Global Fatty Liver Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Fatty Liver Treatment Market Size (2018-2033)
6.2 North America Fatty Liver Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Fatty Liver Treatment Market Size by Country (2018-2023)
6.4 North America Fatty Liver Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Fatty Liver Treatment Market Size (2018-2033)
7.2 Europe Fatty Liver Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Fatty Liver Treatment Market Size by Country (2018-2023)
7.4 Europe Fatty Liver Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Fatty Liver Treatment Market Size (2018-2033)
8.2 Asia-Pacific Fatty Liver Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Fatty Liver Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Fatty Liver Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Fatty Liver Treatment Market Size (2018-2033)
9.2 Latin America Fatty Liver Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Fatty Liver Treatment Market Size by Country (2018-2023)
9.4 Latin America Fatty Liver Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fatty Liver Treatment Market Size (2018-2033)
10.2 Middle East & Africa Fatty Liver Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Fatty Liver Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Fatty Liver Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cardax
11.1.1 Cardax Company Detail
11.1.2 Cardax Business Overview
11.1.3 Cardax Fatty Liver Treatment Introduction
11.1.4 Cardax Revenue in Fatty Liver Treatment Business (2018-2023)
11.1.5 Cardax Recent Development
11.2 Daewoong
11.2.1 Daewoong Company Detail
11.2.2 Daewoong Business Overview
11.2.3 Daewoong Fatty Liver Treatment Introduction
11.2.4 Daewoong Revenue in Fatty Liver Treatment Business (2018-2023)
11.2.5 Daewoong Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Fatty Liver Treatment Introduction
11.3.4 Roche Revenue in Fatty Liver Treatment Business (2018-2023)
11.3.5 Roche Recent Development
11.4 Glenmark
11.4.1 Glenmark Company Detail
11.4.2 Glenmark Business Overview
11.4.3 Glenmark Fatty Liver Treatment Introduction
11.4.4 Glenmark Revenue in Fatty Liver Treatment Business (2018-2023)
11.4.5 Glenmark Recent Development
11.5 GW
11.5.1 GW Company Detail
11.5.2 GW Business Overview
11.5.3 GW Fatty Liver Treatment Introduction
11.5.4 GW Revenue in Fatty Liver Treatment Business (2018-2023)
11.5.5 GW Recent Development
11.6 Limerick BioPharma
11.6.1 Limerick BioPharma Company Detail
11.6.2 Limerick BioPharma Business Overview
11.6.3 Limerick BioPharma Fatty Liver Treatment Introduction
11.6.4 Limerick BioPharma Revenue in Fatty Liver Treatment Business (2018-2023)
11.6.5 Limerick BioPharma Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Fatty Liver Treatment Introduction
11.7.4 Merck Revenue in Fatty Liver Treatment Business (2018-2023)
11.7.5 Merck Recent Development
11.8 Novartis
11.8.1 Novartis Company Detail
11.8.2 Novartis Business Overview
11.8.3 Novartis Fatty Liver Treatment Introduction
11.8.4 Novartis Revenue in Fatty Liver Treatment Business (2018-2023)
11.8.5 Novartis Recent Development
11.9 Orchid
11.9.1 Orchid Company Detail
11.9.2 Orchid Business Overview
11.9.3 Orchid Fatty Liver Treatment Introduction
11.9.4 Orchid Revenue in Fatty Liver Treatment Business (2018-2023)
11.9.5 Orchid Recent Development
11.10 AstraZeneca
11.10.1 AstraZeneca Company Detail
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca Fatty Liver Treatment Introduction
11.10.4 AstraZeneca Revenue in Fatty Liver Treatment Business (2018-2023)
11.10.5 AstraZeneca Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Fatty Liver Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Thiazolidinedione
Table 3. Key Players of Vitamin E
Table 4. Key Players of Metformin Statins
Table 5. Key Players of Polyunsaturated Fatty Acids
Table 6. Key Players of Angiotensin Receptor Blockers
Table 7. Key Players of Pentoxifylline
Table 8. Global Fatty Liver Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Fatty Liver Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 10. Global Fatty Liver Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Fatty Liver Treatment Market Share by Region (2018-2023)
Table 12. Global Fatty Liver Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 13. Global Fatty Liver Treatment Market Share by Region (2024-2033)
Table 14. Fatty Liver Treatment Market Trends
Table 15. Fatty Liver Treatment Market Drivers
Table 16. Fatty Liver Treatment Market Challenges
Table 17. Fatty Liver Treatment Market Restraints
Table 18. Global Fatty Liver Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Fatty Liver Treatment Market Share by Players (2018-2023)
Table 20. Global Top Fatty Liver Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fatty Liver Treatment as of 2022)
Table 21. Ranking of Global Top Fatty Liver Treatment Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Fatty Liver Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Fatty Liver Treatment Product Solution and Service
Table 25. Date of Enter into Fatty Liver Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Fatty Liver Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Fatty Liver Treatment Revenue Market Share by Type (2018-2023)
Table 29. Global Fatty Liver Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 30. Global Fatty Liver Treatment Revenue Market Share by Type (2024-2033)
Table 31. Global Fatty Liver Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Fatty Liver Treatment Revenue Market Share by Application (2018-2023)
Table 33. Global Fatty Liver Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 34. Global Fatty Liver Treatment Revenue Market Share by Application (2024-2033)
Table 35. North America Fatty Liver Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Fatty Liver Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Fatty Liver Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Fatty Liver Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. Europe Fatty Liver Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe Fatty Liver Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 41. Asia-Pacific Fatty Liver Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 42. Asia-Pacific Fatty Liver Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific Fatty Liver Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 44. Latin America Fatty Liver Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Latin America Fatty Liver Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America Fatty Liver Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 47. Middle East & Africa Fatty Liver Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 48. Middle East & Africa Fatty Liver Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Fatty Liver Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 50. Cardax Company Detail
Table 51. Cardax Business Overview
Table 52. Cardax Fatty Liver Treatment Product
Table 53. Cardax Revenue in Fatty Liver Treatment Business (2018-2023) & (US$ Million)
Table 54. Cardax Recent Development
Table 55. Daewoong Company Detail
Table 56. Daewoong Business Overview
Table 57. Daewoong Fatty Liver Treatment Product
Table 58. Daewoong Revenue in Fatty Liver Treatment Business (2018-2023) & (US$ Million)
Table 59. Daewoong Recent Development
Table 60. Roche Company Detail
Table 61. Roche Business Overview
Table 62. Roche Fatty Liver Treatment Product
Table 63. Roche Revenue in Fatty Liver Treatment Business (2018-2023) & (US$ Million)
Table 64. Roche Recent Development
Table 65. Glenmark Company Detail
Table 66. Glenmark Business Overview
Table 67. Glenmark Fatty Liver Treatment Product
Table 68. Glenmark Revenue in Fatty Liver Treatment Business (2018-2023) & (US$ Million)
Table 69. Glenmark Recent Development
Table 70. GW Company Detail
Table 71. GW Business Overview
Table 72. GW Fatty Liver Treatment Product
Table 73. GW Revenue in Fatty Liver Treatment Business (2018-2023) & (US$ Million)
Table 74. GW Recent Development
Table 75. Limerick BioPharma Company Detail
Table 76. Limerick BioPharma Business Overview
Table 77. Limerick BioPharma Fatty Liver Treatment Product
Table 78. Limerick BioPharma Revenue in Fatty Liver Treatment Business (2018-2023) & (US$ Million)
Table 79. Limerick BioPharma Recent Development
Table 80. Merck Company Detail
Table 81. Merck Business Overview
Table 82. Merck Fatty Liver Treatment Product
Table 83. Merck Revenue in Fatty Liver Treatment Business (2018-2023) & (US$ Million)
Table 84. Merck Recent Development
Table 85. Novartis Company Detail
Table 86. Novartis Business Overview
Table 87. Novartis Fatty Liver Treatment Product
Table 88. Novartis Revenue in Fatty Liver Treatment Business (2018-2023) & (US$ Million)
Table 89. Novartis Recent Development
Table 90. Orchid Company Detail
Table 91. Orchid Business Overview
Table 92. Orchid Fatty Liver Treatment Product
Table 93. Orchid Revenue in Fatty Liver Treatment Business (2018-2023) & (US$ Million)
Table 94. Orchid Recent Development
Table 95. AstraZeneca Company Detail
Table 96. AstraZeneca Business Overview
Table 97. AstraZeneca Fatty Liver Treatment Product
Table 98. AstraZeneca Revenue in Fatty Liver Treatment Business (2018-2023) & (US$ Million)
Table 99. AstraZeneca Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Fatty Liver Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Fatty Liver Treatment Market Share by Type: 2022 VS 2033
Figure 3. Thiazolidinedione Features
Figure 4. Vitamin E Features
Figure 5. Metformin Statins Features
Figure 6. Polyunsaturated Fatty Acids Features
Figure 7. Angiotensin Receptor Blockers Features
Figure 8. Pentoxifylline Features
Figure 9. Global Fatty Liver Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 10. Global Fatty Liver Treatment Market Share by Application: 2022 VS 2033
Figure 11. Hospitals and Clinics Case Studies
Figure 12. Others Case Studies
Figure 13. Fatty Liver Treatment Report Years Considered
Figure 14. Global Fatty Liver Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Fatty Liver Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Fatty Liver Treatment Market Share by Region: 2022 VS 2033
Figure 17. Global Fatty Liver Treatment Market Share by Players in 2022
Figure 18. Global Top Fatty Liver Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fatty Liver Treatment as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Fatty Liver Treatment Revenue in 2022
Figure 20. North America Fatty Liver Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Fatty Liver Treatment Market Share by Country (2018-2033)
Figure 22. United States Fatty Liver Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Fatty Liver Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Fatty Liver Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Fatty Liver Treatment Market Share by Country (2018-2033)
Figure 26. Germany Fatty Liver Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Fatty Liver Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Fatty Liver Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Fatty Liver Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Fatty Liver Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Fatty Liver Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Fatty Liver Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Fatty Liver Treatment Market Share by Region (2018-2033)
Figure 34. China Fatty Liver Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Fatty Liver Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Fatty Liver Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Fatty Liver Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Fatty Liver Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Fatty Liver Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Fatty Liver Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Fatty Liver Treatment Market Share by Country (2018-2033)
Figure 42. Mexico Fatty Liver Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Fatty Liver Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Fatty Liver Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Fatty Liver Treatment Market Share by Country (2018-2033)
Figure 46. Turkey Fatty Liver Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Fatty Liver Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Cardax Revenue Growth Rate in Fatty Liver Treatment Business (2018-2023)
Figure 49. Daewoong Revenue Growth Rate in Fatty Liver Treatment Business (2018-2023)
Figure 50. Roche Revenue Growth Rate in Fatty Liver Treatment Business (2018-2023)
Figure 51. Glenmark Revenue Growth Rate in Fatty Liver Treatment Business (2018-2023)
Figure 52. GW Revenue Growth Rate in Fatty Liver Treatment Business (2018-2023)
Figure 53. Limerick BioPharma Revenue Growth Rate in Fatty Liver Treatment Business (2018-2023)
Figure 54. Merck Revenue Growth Rate in Fatty Liver Treatment Business (2018-2023)
Figure 55. Novartis Revenue Growth Rate in Fatty Liver Treatment Business (2018-2023)
Figure 56. Orchid Revenue Growth Rate in Fatty Liver Treatment Business (2018-2023)
Figure 57. AstraZeneca Revenue Growth Rate in Fatty Liver Treatment Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed